PortfoliosLab logo
OSCR vs. MRK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between OSCR and MRK is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

OSCR vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oscar Health, Inc. (OSCR) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%December2025FebruaryMarchAprilMay
-50.83%
23.75%
OSCR
MRK

Key characteristics

Sharpe Ratio

OSCR:

-0.31

MRK:

-1.52

Sortino Ratio

OSCR:

0.27

MRK:

-2.13

Omega Ratio

OSCR:

1.03

MRK:

0.72

Calmar Ratio

OSCR:

-0.20

MRK:

-0.96

Martin Ratio

OSCR:

-0.43

MRK:

-1.76

Ulcer Index

OSCR:

31.36%

MRK:

22.68%

Daily Std Dev

OSCR:

74.67%

MRK:

26.31%

Max Drawdown

OSCR:

-94.15%

MRK:

-68.62%

Current Drawdown

OSCR:

-53.47%

MRK:

-41.52%

Fundamentals

Market Cap

OSCR:

$3.36B

MRK:

$208.01B

EPS

OSCR:

$0.10

MRK:

$6.88

PE Ratio

OSCR:

130.00

MRK:

12.04

PS Ratio

OSCR:

0.37

MRK:

3.25

PB Ratio

OSCR:

3.31

MRK:

4.52

Total Revenue (TTM)

OSCR:

$7.04B

MRK:

$63.92B

Gross Profit (TTM)

OSCR:

$7.04B

MRK:

$51.75B

EBITDA (TTM)

OSCR:

-$103.36M

MRK:

$27.30B

Returns By Period

In the year-to-date period, OSCR achieves a 27.31% return, which is significantly higher than MRK's -22.97% return.


OSCR

YTD

27.31%

1M

36.66%

6M

26.37%

1Y

-22.86%

5Y*

N/A

10Y*

N/A

MRK

YTD

-22.97%

1M

-7.25%

6M

-24.95%

1Y

-39.94%

5Y*

3.98%

10Y*

6.17%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OSCR vs. MRK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OSCR
The Risk-Adjusted Performance Rank of OSCR is 4141
Overall Rank
The Sharpe Ratio Rank of OSCR is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of OSCR is 4545
Sortino Ratio Rank
The Omega Ratio Rank of OSCR is 4444
Omega Ratio Rank
The Calmar Ratio Rank of OSCR is 4040
Calmar Ratio Rank
The Martin Ratio Rank of OSCR is 4343
Martin Ratio Rank

MRK
The Risk-Adjusted Performance Rank of MRK is 22
Overall Rank
The Sharpe Ratio Rank of MRK is 00
Sharpe Ratio Rank
The Sortino Ratio Rank of MRK is 22
Sortino Ratio Rank
The Omega Ratio Rank of MRK is 22
Omega Ratio Rank
The Calmar Ratio Rank of MRK is 11
Calmar Ratio Rank
The Martin Ratio Rank of MRK is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

OSCR vs. MRK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Oscar Health, Inc. (OSCR) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current OSCR Sharpe Ratio is -0.31, which is higher than the MRK Sharpe Ratio of -1.52. The chart below compares the historical Sharpe Ratios of OSCR and MRK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.00December2025FebruaryMarchAprilMay
-0.31
-1.52
OSCR
MRK

Dividends

OSCR vs. MRK - Dividend Comparison

OSCR has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 4.16%.


TTM20242023202220212020201920182017201620152014
OSCR
Oscar Health, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MRK
Merck & Co., Inc.
4.16%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%3.12%

Drawdowns

OSCR vs. MRK - Drawdown Comparison

The maximum OSCR drawdown since its inception was -94.15%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for OSCR and MRK. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%December2025FebruaryMarchAprilMay
-53.47%
-41.52%
OSCR
MRK

Volatility

OSCR vs. MRK - Volatility Comparison

Oscar Health, Inc. (OSCR) has a higher volatility of 27.67% compared to Merck & Co., Inc. (MRK) at 10.21%. This indicates that OSCR's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%December2025FebruaryMarchAprilMay
27.67%
10.21%
OSCR
MRK

Financials

OSCR vs. MRK - Financials Comparison

This section allows you to compare key financial metrics between Oscar Health, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
2.39B
15.53B
(OSCR) Total Revenue
(MRK) Total Revenue
Values in USD except per share items

OSCR vs. MRK - Profitability Comparison

The chart below illustrates the profitability comparison between Oscar Health, Inc. and Merck & Co., Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%100.0%20212022202320242025
100.0%
78.0%
(OSCR) Gross Margin
(MRK) Gross Margin
OSCR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Oscar Health, Inc. reported a gross profit of 2.39B and revenue of 2.39B. Therefore, the gross margin over that period was 100.0%.

MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.

OSCR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Oscar Health, Inc. reported an operating income of -147.73M and revenue of 2.39B, resulting in an operating margin of -6.2%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.

OSCR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Oscar Health, Inc. reported a net income of -153.55M and revenue of 2.39B, resulting in a net margin of -6.4%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.